Supernus Pharmaceuticals (SUPN) PT Raised to $60 at TD Cowen
Tweet Send to a Friend
TD Cowen analyst Stacy Ku raised the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $60.00 (from $45.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
